RE: Funding situation5 Nov 2024 19:25
I also think Stephen that they didn’t quite hit their targeted £6m, plus there were costs to be taken off the total they did manage to raise.
An extra £200k per month for FDA process (hopefully only 3 months) plus we’re paying clinical trials in the US which are being carried out by our secret US partner. Hush hush.
That said , GDR should receive another R &D tax refund as long as Rachel Reeves hasn’t decided to cut those as well.
I think it will be tight timing wise but it’s possible GDR COULD survive until April, by then perhaps NHs England will finally finally pull their fingers out and decide to adopt the PoC tests. NHSS might also announce a roll out but helpfully they not GDR seem to know when a decision on a possible rollout will take place. Just keep everyone guessing.
Frustrating as always that sales are going to take longer still than anyone thought possible but it is what it is. We had 3 sentences from Gino yesterday so that’s it for another 6 months probably from him. He’ll have to say sobering though when they delay the next set of results . All is not lost yet. More patience required